dipyridamole has been researched along with Colonic Diseases in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Colonic Diseases: Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Updike, SJ | 1 |
| Bozdech, MJ | 1 |
| Johnson, CA | 1 |
| Zimmerman, SW | 1 |
1 other study available for dipyridamole and Colonic Diseases
| Article | Year |
|---|---|
Management of fulminating thrombotic thrombocytopenic purpura.
Topics: Acute Kidney Injury; Colonic Diseases; Colostomy; Dipyridamole; Humans; Male; Middle Aged; Plasma Ex | 1981 |